🌍 Dünya Astım Günü
260 milyon kişi astımla mücadele ediyor…
Her yıl 450 bin can kaybediyoruz.
Peki asıl sorun ne?
En etkili tedavi hâlâ ulaşılamıyor.
Toraks Bülteni Podcast’te konuştuk: gerçekleri, sağlık politikalarını ve çözümleri 👇
https://t.co/CMl6EJvg68
SİGARA KÖKENLİ BİR KOAH HASTASI OLARAK:
Türk Toraks Derneği’nin “Dünyanın Değişimi, Nefesin Geleceği” konulu 28. Yıllık Kongresinde “Diyalektik Açıdan Atatürk Devrimleri ve Cumhuriyet Tarihi” konulu bir konferans için Antalya’dayım.
Hem Genel Ahlâk hem Meslek Ahlâkı sahibi olan doktorlarımıza saygı ve sevgi gösterelim, onları CANIMIZ gibi koruyalım.
#türktoraksderneğikongresi2025
Most acute asthma attacks/exacerbations are preventable with correct management. In this podcast 'Asthma with Experts' hosted by GINA, Professor Alvaro Cruz, shares his views on preventing acute asthma exacerbations/attacks.
Apple: https://t.co/CCBqFWavQQ
There is strong evidence for prescribing combination inhaled corticosteroid-formoterol in one inhaler for relief of asthma symptoms in adults/adolescents. It reduces severe asthma attacks & emergency visits. Short-acting beta2-agonist relievers do https://t.co/7nrQE5rHeG
The 2024 GINA diagnostic flowchart for clinical practice has been revised. Many health professionals don’t have access (or timely access) to spirometry. While less reliable than spirometry peak expiratory flow is better than relying on symptoms alone. https://t.co/Cm9ADXlUYD
Please share this recommendation from GINA: Adults and adolescents with #MILD#asthma should be treated with inhaled corticosteroid (ICS) containing therapy either regularly every day or with low-dose ICS–formoterol taken as needed for symptom relief. See https://t.co/TlA9iqzJtt
An asthma attack is a signal that something went wrong! -1:
Is the person prescribed an inhaled corticosteroid? If not, why not? GINA recommends that everyone with asthma should be prescribed an ICS, either regularly, or with as-needed ICS-formoterol. https://t.co/Cm9ADXlUYD
ERR: Montelukast is not associated with suicide-related events in asthma patients. Age may be a possible effect modifier on the association between montelukast and anxiety and sleeping disorders, with a higher risk of adverse events in the elderly. https://t.co/gxBI3wiumU
Q&A: What to know about air quality alert days: wildfire smoke, smog and pollution are increasingly present in the air we breathe. What is this polluted air doing to our bodies? https://t.co/1ABuHP66hV
This update includes specific advice about how to write an asthma action plan depending on the patient’s usual treatment (Track 1 or Track 2). Please share: @PCRSUK@IPCRG @RespNprang @rcgp @BTSrespiratory
The use of multiple electronic nicotine delivery products is on the rise. While the potential harm associated with dual- or poly-product usage is not yet clear, this study suggests that dual cigarette smoke and IQOS may be detrimental to lung health. https://t.co/lFXwtCuHId
🔬🧬Exciting new research! An article on the profiling of apoptosis-associated microRNA expressions of lung adenocarcinoma. 🫁🔍 Check it out here: https://t.co/s6sz0LGWvL. Fascinating insights into potential biomarkers and therapeutic targets. #LungAdenocarcinoma#MicroRNAs
📢 Latest issue is out now! You can see the full content of the March-April 2023 issue on our website: https://t.co/Y6VHKKEUCL.
#Thoracic#pulmonary#OpenAccess
World Asthma Day - May 2, 2023.
The Asthma care for All message promotes the development and implementation of effective asthma management programs in all resource countries. #WorldAsthmaDay#GINA
For more information: https://t.co/UR7cWCcInD
Join us for a World Asthma Day advocacy panel discussion on the GINA 2023 Report, and the ERS & GINA perspectives on asthma and the environment, looking to a healthier future.
2 May, 2023
Online
Register: https://t.co/6Oa9gcdiyT
#WorldAsthmaDay